In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-12 of 12 for your search:
Drug:  ribavirin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 5 and over
Sponsor: Other
Protocol IDs: ID03-0010, NCT00500578

2.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 25 to 75
Sponsor: Other
Protocol IDs: O2006-415, NCT00375661

3.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: KMUH-IRB-960043, NCT00834860

4.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1379.00, FHCRC-1379.00, NCI-G01-1929, CDR0000068540, NCT00014391

5.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 2 and over
Sponsor: NCI, Other
Protocol IDs: 1290.00, FHCRC-1290.00, NCI-G01-1939, CDR0000068593, NCT00016081

6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 1 and over
Sponsor: Other
Protocol IDs: 2323.00, 6895, NCT00867139

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: Ribavirin-002, NCT01056523

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI
Protocol IDs: UARK-92016, NCI-T92-0173O, T92-0173

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CR0620KB, REC:06-112, NCT00559091

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P7977-2025, NCT01559844

11.

Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Completed
Age: No age specified
Sponsor: NCI, Other
Protocol IDs: VICC MEL0651, VU-VICC-MEL-0651, VU-VICC-060614, NCT00897312

12.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Closed
Age: 18 to 59
Sponsor: Other
Protocol IDs: 10-218, NCT01268579
New Search